IRCT201403092624N12已完成3 期
Evaluation of the effect of cabergoline (dopamine receptor agonist) on the size and symptoms of uterine myoma in women with myoma.
Vice chancellor for research ,Iran University of Medical Sciences.0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 40 years（—）
- 性别
- Female
入选标准
- •symptomatic myoma including abnormal uterine bleeding ( after excluding the other etiologies), pelvic pain, and myoma in ultrasound with a minimum size of 2 centimeters.
- •Exclusion criteria : severe bleeding; pregnancy; breast feeding; using any hormone or sedative; any other pathology in ultrasound; any known hormonal problems and any conditions need to an emergency treatment.
排除标准
- 未提供
研究者
相似试验
招募中
3 期
the effect cabergoline on reducing pain in endometriosis patientsEndometriosis.EndometriosisIRCT20181030041503N6Mashhad University of Medical Sciences72
尚未招募
Unknown
Comparison of the effect of Cabergoline versus Dienogest on markers in endometriosisCTRI/2023/04/051886il
尚未招募
Unknown
To study the benefits of addition of Cabergoline to Metformin in women with PCOSCTRI/2024/08/071776il
招募中
3 期
The effect of Cabergoline on blood glucose control in type 2 diabetic patientsIRCT20100314003565N9Tabriz University of Medical Sciences50
招募中
3 期
Comparative study between cabergoline and intravenous calcium in the prevention of ovarian hyper stimulation in women with polycystic ovarian disease undergoing Intracytoplasmic sperm injection (ICSI ).subfertilityovarian hyperstimulationPoly cystic ovarian diseaseReproductive Health and Childbirth - Fertility including in vitro fertilisationACTRN12613000904774Eman Elkattan100